Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medifast (MED) Other Non-Current Assets (2016 - 2025)

Historic Other Non-Current Assets for Medifast (MED) over the last 16 years, with Q4 2025 value amounting to $7.8 million.

  • Medifast's Other Non-Current Assets fell 1902.35% to $7.8 million in Q4 2025 from the same period last year, while for Dec 2025 it was $7.8 million, marking a year-over-year decrease of 1902.35%. This contributed to the annual value of $7.8 million for FY2025, which is 1902.35% down from last year.
  • Medifast's Other Non-Current Assets amounted to $7.8 million in Q4 2025, which was down 1902.35% from $7.0 million recorded in Q3 2025.
  • Over the past 5 years, Medifast's Other Non-Current Assets peaked at $15.8 million during Q3 2023, and registered a low of $3.1 million during Q1 2021.
  • Its 5-year average for Other Non-Current Assets is $10.3 million, with a median of $11.4 million in 2024.
  • In the last 5 years, Medifast's Other Non-Current Assets soared by 28643.96% in 2022 and then crashed by 3607.12% in 2025.
  • Quarter analysis of 5 years shows Medifast's Other Non-Current Assets stood at $6.5 million in 2021, then surged by 92.58% to $12.5 million in 2022, then grew by 17.61% to $14.6 million in 2023, then crashed by 34.01% to $9.7 million in 2024, then dropped by 19.02% to $7.8 million in 2025.
  • Its Other Non-Current Assets was $7.8 million in Q4 2025, compared to $7.0 million in Q3 2025 and $8.0 million in Q2 2025.